IL-2 therapy promotes suppressive ICOS + Treg expansion in melanoma patients
Activated T cells within a CD4 + ICOS + subset greatly increase during IL-2 therapy. We developed a multicolor FACS staining panel to track changes in multiple lymphocyte subsets in peripheral blood of patients with melanoma during cycle 1 of HD IL-2 ther...